Novel Nano Drug‐Loaded Hydrogel Coatings for the Prevention and Treatment of CAUTI

Abstract Catheter‐associated urinary tract infection (CAUTI) is a prevalent type of hospital‐acquired infection, affecting approximately 15% to 25% of patients with urinary catheters. Long‐term use of the catheter can lead to colonization of microorganisms and biofilm formation, and may develop into bacterial CAUTI. However, the frequent replacement of catheters in clinical settings can result in tissue damage, inflammation, ulceration, and additional complications, causing discomfort and pain for patients. In light of these challenges, a novel nanodrug‐supported hydrogel coating called NP‐AM/FK@OMV‐P/H has been developed in this study. Through in vitro experiments, it is confirmed that OMV nano‐loaded liquid gel coating has an effective reaction against E.coli HAase and releases antibacterial drugs. This coating has also demonstrated strong inhibition of E.coli and has shown the ability to inhibit the formation of bacterial biofilm. These findings highlight the potential of the OMV nanoparticle gel coating in preventing and treating bacterial infections. Notably, NP‐AM/FK@OMV‐P/H has exhibited greater efficacy against multidrug‐resistant E.coli associated with UTIs compared to coatings containing single antimicrobial peptides or antibiotics. Additionally, it has demonstrated good biosecurity. In conclusion, the NP‐AM/FK@OMV‐P/H coating holds great potential in providing benefits to patients with CAUTI.